<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00365014</url>
  </required_header>
  <id_info>
    <org_study_id>02-0036</org_study_id>
    <nct_id>NCT00365014</nct_id>
  </id_info>
  <brief_title>Progression of Hematopoietic Diseases in Shanghai, China</brief_title>
  <official_title>Analysis of Disease Progression for Aplastic Anemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia and Benzene Poisoning in Shanghai, China.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fudan University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Cincinnati</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>ExxonMobil Biomedical Sciences, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>British Petroleum P.L.C.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chevron Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>ConocoPhillips</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Exxon Mobil</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Marathon Ashland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shell Chemicals</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to identify and characterize blood diseases presenting at
      Shanghai hospitals and to compare them with respect to clinical presentation, phenotype,
      molecular characteristics, benzene or other exposures and genetic susceptibility.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to identify and characterize blood diseases presenting at
      Shanghai hospitals and to compare them with respect to clinical presentation, phenotype,
      molecular characteristics, benzene or other exposures and genetic susceptibility. The format
      for these studies is a set of clinical series superimposed on a case-control design that
      enables integration of detailed clinical and molecular characterizations of disease
      pathogenesis together with an evaluation of potential confounding and interacting factors
      within a structured statistical analysis of benzene exposure.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2003</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>blood diseases presenting at Shanghai hospitals</measure>
    <time_frame>hospital stay</time_frame>
    <description>characterization of people with blood diseases presenting at Shanghai hospitals</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">10757</enrollment>
  <condition>Hematologic Diseases</condition>
  <arm_group>
    <arm_group_label>Blood disease patients</arm_group_label>
    <description>People with blood diseases presenting at Shanghai hospitals</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with blood diseases
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Men and women 18 years or older Diagnosis of hematologic abnormality

        Exclusion Criteria:

        Children Non hematologic diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard D Irons, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado at Denver and Health Sciences Ctr.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Joint Sino-US Clinical and Molecular Laboratory (JCML)</name>
      <address>
        <city>Shanghai</city>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 14, 2006</study_first_submitted>
  <study_first_submitted_qc>August 14, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 16, 2006</study_first_posted>
  <last_update_submitted>July 19, 2013</last_update_submitted>
  <last_update_submitted_qc>July 19, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 23, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>aplastic anemia</keyword>
  <keyword>myelodysplastic syndromes</keyword>
  <keyword>cytopenias</keyword>
  <keyword>acute myeloid leukemia</keyword>
  <keyword>myelodysplastic/myeloproliferative diseases</keyword>
  <keyword>benzene poisoning</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myelodysplastic Syndromes</mesh_term>
    <mesh_term>Hematologic Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

